Proteome Sciences plc

1.38pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:PRMHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (12.84%)
Div yield —
ROE —
Medical Devices
Beta (5Y) 0.21
PE TTM —
TSR TTM (23.97%)
Mkt cap £4.840M
ROIC (22.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
1.54p
11.85%
(69.84%)
Hold 2|8|8|4|2
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.02
0.03
0.02
0.03
4.30%
20.93%
10.66%
19.56%
Revenue£M
0.249
0.243
0.244
0.238
16.90%
11.11%
6.71%
(0.29%)
Peers (US$7.315M)
Cap (US$)
PE
3.207M
—
7.404M
—
Capital
TTM
5Y
10Y
Leveragex
0.041
(0.290)
(0.230)
EBIT/Intx
1.331
0.508
0.460
Own earn%
64.67
(0.30)
0.13
Sh yield%
40.82
57.18
55.42
Owners
Insiders/Inst%
4.96
33.57
Short interest%
0.83
SBC / revenue%
5.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
12–20
$1 testx
—
Incr. ROIC%
22